Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 106, Issue 5, 2010, Pages 428-434

  Genovese, Raymond F ^a   Sun, Wei ^a   Johnson, Christina C ^a   Ditargiani, Robert C ^a   Doctor, Bhupendra P ^a   Saxena, Ashima ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; OXOTREMORINE; SOMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL WARFARE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; LIVER CONGESTION; LUNG CONGESTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SINGLE DRUG DOSE; TASK PERFORMANCE;

ANIMALS; BUTYRYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; MOTOR ACTIVITY; ORGANOTHIOPHOSPHORUS COMPOUNDS; OXOTREMORINE; RATS; SOMAN;

RATTUS;

EID: 77951030229     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00508.x     Document Type: Article

References (30)

1. Holstege CP, Kirk M, Sidell FR. Chemical warfare. Nerve agent poisoning. Crit Care Clin 1997 13 : 923 942.
2. Somani SM (ed Chemical Warfare Agents. Academic Press
3. Ross MC, Broomfield CA, Cerasoli DM, Doctor BP, Lenz DE, Maxwell DM et al. Nerve agent bioscavenger: development of a new approach to protect against organophosphorus exposure. In : Tuorinsky SD (ed Textbooks of Military Medicine: Medical Aspects of Chemical Warfare.
4. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV, Lenz DE. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 1991 259 : 633 638.
5. Ashani Y, Shapira S, Levy D, Wolfe AD, Doctor BP, Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem Pharmacol 1991 41 : 37 41.
6. Doctor BP, Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interaction 2005 157-158 : 167 171.
7. Lenz DE, Maxwell DM, Koplovitz I, Clark CR, Capacio BR, Cerasoli DM et al. Protection against soman poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem Biol Interact 2005 158 : 205 210.
8. Raveh L, Grauer E, Grunwald J, Cohen E, Ashani Y. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol Appl Pharmacol 1997 145 : 43 53.
9. Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. Biochem Pharmacol 1993 45 : 2465 2474.
10. Clark MG, Sun W, Myers TM, Bansal R, Doctor BP, Saxena A. Effects of physostigmine and human butyrylcholinesterase on acoustic startle reflex and prepulse inhibition in C57BL/6J mice. Pharmacol Biochem Behav 2005 81 : 497 505.
11. Genovese RF, Doctor BP. Behavioral and pharmacological evaluation of butyrylcholinesterase in rats. Pharmacol Biochem Behav 1995 51 : 647 654.
12. Myers TM, Sun W, Bonvillain AJ et al. Human butyrylcholinesterase: physiological and behavioral safety in rhesus monkeys. In : Proceedings of the USAMRDC Medical Defense Bioscience Review 2004, Hunt Valley, MD, USAMRDC
13. Saxena A, Sun W, Luo C, Doctor BP. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice. Chem Biol Interact 2005 157-158 : 199 203. (Pubitemid 41757651)
14. Sun W, Doctor BP, Saxena A. Safety and pharmacokinetics of human serum butyrylcholinesterase in guinea pigs. Chem Biol Interact 2005 157-158 : 428 429.
15. Oberist FW, Christenson MK. Regeneration of erythrocyte and brain cholinesterase activity in rats after sub-lethal exposures to GB vapors. J Pharmacol Exp Ther 1956 116 : 216 219.
16. Woodard CL, Calamaio CA, Kaminskis A, Anderson DR, Harris LW, Martin DG. Erythrocyte and plasma cholinesterase activity in male and female rhesus monkeys before and after exposure to sarin. Fundam Appl Toxicol 1994 23 : 342 347.
17. Worek F, Eyer P, Szinicz L. Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases. Arch Toxicol 1998 72 : 580 587.
18. Van der Schans MJ, Polhuisjs M, Van Dijk C, Degenhardt CE, Pleijseir K, Langenberg JP et al. Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE. Arch Toxicol 2004 78 : 508 524.
19. Wolfe AD, Blick DW, Murphy MR, Miller SA, Gentry MK, Hartgraves SL et al. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol Appl Pharmacol 1992 117 : 189 193.
20. Genovese RF, Benton BJ, Johnson CC, Jakubowski EM. Assessment of low-level whole-body soman vapor exposure in rats. Neurotoxicol Teratol 2009 31 : 110 118.
21. Genovese RF, Benton BJ, Lee EH, Shippee SJ, Jakubowski EM. Behavioral and biochemical evaluation of sub-lethal inhalation exposure to VX in rats. Toxicology 2007 232 : 109 118.
22. Genovese RF, Mioduszewski RJ, Benton JB, Pare MA, Cooksey JA. Behavioral evaluation of rats following low-level inhalation exposure to sarin. Pharmacol Biochem Behav 2009 91 : 517 525.
23. Genovese RF, Elsmore TF, Witkin JM. Relationship of behavioral effects of aprophen, atropine and scopolamine to antagonism of behavioral effects of physostigmine. Pharmacol Biochem Behav 1990 37 : 117 122.
24. Genovese RF, Elsmore TF, King LR. Tolerance to oxotremorine's effects on schedule controlled behavior in physostigmine tolerant rats. Life Sci 1988 43 : 571 576.
25. Saxena A, Luo C, Doctor BP. Developing procedures for the large-scale purification of human serum butyrylcholinesterase. Protein Expr Purif 2008 61 : 191 196.
26. Ashani Y, Pistinner S. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model. Toxicol Sci 2004 77 : 358 367.
27. Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholesterase activity using thiocholine esters as substrates. Biochem Pharmacol 1961 7 : 88 95.
28. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 1999 288 : 73 90.
29. Bosković B, Kovacević V, Jovanović D. 2-PAM chloride, Hi-6 and HGG 12 in soman and tabun poisoning. Fundam Appl Toxicol 1984 4 : 106 115.
30. Martin JR, Overstreet DH, Driscoll P, Bättig K. Effects of scopolamine, pilocarpine, and oxotremorine on the exploratory behavior of two psychogenetically selected lines of rats in a complex maze. Psychopharmacology (Berl) 1981 72 : 135 142.